ECHOMARKETING Co.,Ltd. Logo

ECHOMARKETING Co.,Ltd.

Global agency accelerating sales with data-driven, full-funnel digital marketing.

230360 | KO

Overview

Corporate Details

ISIN(s):
KR7230360000
LEI:
Country:
South Korea
Address:
서울특별시 송파구 올림픽로35다길 42 한국루터회관 9,10,15층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ECHOMARKETING Co., Ltd. is a global digital marketing agency focused on accelerating client sales growth. The company designs and executes data-driven, full-funnel marketing strategies that span the entire customer journey. Its comprehensive service suite includes strategic planning, creative production optimized through A/B testing, in-house campaign management, advanced data analysis, and CRM. The firm operates with a unique "UNIT" system, assembling cross-functional teams of specialists from areas such as e-commerce, finance, media buying, and data science to address specific client objectives. With a global presence in over 50 countries, ECHOMARKETING provides solutions in performance marketing, programmatic advertising, and search marketing management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Notice of Dividend Amount
수시공시의무관련사항(공정공시) (2025년(제23기) 3분기배당 계획)
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-11 00:00
Transaction in Own Shares
자기주식취득결과보고서
Korean 30.4 KB
2025-08-11 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.6 KB
2025-08-11 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.5 KB
2025-08-11 00:00
Share Issue/Capital Change
주식소각결정
Korean 9.0 KB
2025-07-15 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
Korean 32.6 KB
2025-07-15 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식취득결정)
Korean 35.4 KB
2025-05-16 00:00
Board/Management Information
대표이사변경
Korean 9.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.2 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.1 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 24.5 KB

Automate Your Workflow. Get a real-time feed of all ECHOMARKETING Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ECHOMARKETING Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ECHOMARKETING Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.